119th Congress
H.R. 2821

Requires FDA rule on non-animal drug testing terms

Tells the FDA to publish a rule within one year that swaps mentions of animal tests for nonclinical tests in its rules for new drug applications.

  • Replaces animal test, data, and study wording with nonclinical wording in FDA drug rules
  • Applies to FDA rules for investigational new drug applications
  • Rule must be published within one year of the bill becoming law
  • Rule takes effect right away as an interim final rule

Passed the House · Senate's turn

Read the full bill